News

Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...
The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.
(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
The current fear is that bird flu, H5N1, will become the next big pandemic. Only the mRNA platform is nimble enough to ...
The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...
Now that Covid vaccines are no longer recommended for healthy children and pregnant people, boosters could be a lot more ...
Canadian doctors and scientists say Robert F. Kennedy Jr.'s firing of an immunization advisory committee south of the border ...
A large prospective cohort study in Germany found no statistically significant increase in major birth defects following ...
A new COVID variant - NB 1.8.1 - is in New Jersey. Parents can take steps to protect their children from COVID this summer.